September 30, 2015 – Sirona Biochem Corp.
Vancouver, British Columbia – September 30, 2015 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt/Xetra®: ZSB) today provides an investor presentation and update.
I would like to take this opportunity to provide you with a video of a recent investor event held at Canaccord Genuity Wealth Management in Vancouver, BC.
The purpose of the video is to provide an update on the execution of our strategic plan, which has been going better than we have expected. We are progressing our partnering discussions with a number of major global corporations, which will lead to the closing of a major transaction with SBM-TFC-1067. Our other partnered projects with Valeant and Fosun are also progressing to plan.
With the recent addition of $1M to the treasury from the exercising of warrants and options, we now have $2M of cash on hand, instead of the amount showing on slide 5. The management team is committed to delivering our business priorities and Sirona is very close to reaching a major inflection point, which is summarized in slide 12.
I sincerely appreciate the ongoing support.
Dr. Howard Verrico
CEO, Chairman of the Board, Founder
Sirona Biochem Corp.